Further research—studying various neuroinflammatory molecules that could promote pathophysiologic processes in AD patients—found that concentrations of tau protein, MMP-1, and -10 are higher in CSF samples from AD patients compared with controls. This evidence concerns the gene MMP1 and Alzheimer disease.